Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18073 | 505 | 50.8 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CALPAIN CATHEPSIN HYPOTHESIS | Author keyword | 8 | 100% | 1% | 5 |
2 | OSMOTIC SENSITIVITY | Author keyword | 5 | 44% | 2% | 8 |
3 | LYSOSOME STABILITY | Author keyword | 4 | 75% | 1% | 3 |
4 | LYSOSOMAL MEMBRANE PERMEABILIZATION | Author keyword | 3 | 30% | 2% | 9 |
5 | REDOX ACTIVE IRON | Author keyword | 3 | 32% | 1% | 7 |
6 | P MED UHL | Address | 2 | 67% | 0% | 2 |
7 | TORAT NEUROSURG | Address | 1 | 19% | 1% | 7 |
8 | CELL DEATH METAB UNIT | Address | 1 | 100% | 0% | 2 |
9 | DIVALENT POSITIVELY CHARGED ION | Author keyword | 1 | 100% | 0% | 2 |
10 | LATENCY LOSS | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MEDIATED HEPATOCYTE APOPTOSIS | 21 | 51% | 6% | 29 |
2 | INTRALYSOSOMAL IRON | 11 | 54% | 3% | 14 |
3 | CATHEPSIN B CONTRIBUTES | 8 | 50% | 2% | 12 |
4 | J 774 CELLS | 6 | 80% | 1% | 4 |
5 | ALLOXAN CYTOTOXICITY | 6 | 100% | 1% | 4 |
6 | LYSOSOMAL MEMBRANE PERMEABILIZATION | 4 | 20% | 4% | 19 |
7 | CELL REPAIR MECHANISM | 3 | 100% | 1% | 3 |
8 | ENSUING APOPTOSIS | 3 | 100% | 1% | 3 |
9 | B CONTRIBUTES | 2 | 38% | 1% | 5 |
10 | CATHEPSIN DEPENDENT APOPTOSIS | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lysosomal membrane permeabilization in cell death | 2008 | 309 | 164 | 40% |
Combating apoptosis and multidrug resistant cancers by targeting lysosomes | 2013 | 26 | 95 | 55% |
Lysosomes and lysosomal cathepsins in cell death | 2012 | 83 | 164 | 35% |
Lysosomes as "Suicide Bags" in Cell Death: Myth or Reality? | 2009 | 84 | 53 | 49% |
Lysosomes in cell death | 2004 | 342 | 102 | 47% |
The lysosome: from waste bag to potential therapeutic target | 2013 | 44 | 184 | 26% |
Lysosomal proteins in cell death and autophagy | 2015 | 1 | 72 | 31% |
Lysosomal involvement in cell death and cancer | 2009 | 91 | 116 | 37% |
Lysosomal pathways to cell death and their therapeutic applications | 2012 | 33 | 51 | 47% |
Lysosornes as targets for cancer therapy | 2005 | 125 | 21 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P MED UHL | 2 | 67% | 0.4% | 2 |
2 | TORAT NEUROSURG | 1 | 19% | 1.4% | 7 |
3 | CELL DEATH METAB UNIT | 1 | 100% | 0.4% | 2 |
4 | NEUROL MOL HUMAN GENET | 1 | 50% | 0.4% | 2 |
5 | GENOTOX ST S PONSE | 1 | 40% | 0.4% | 2 |
6 | CLIN PATHOL CLIN GENET | 1 | 21% | 0.8% | 4 |
7 | BENTO ROCHA CABRAL | 1 | 50% | 0.2% | 1 |
8 | BIOL MOL UNIDAD BIOMED | 1 | 50% | 0.2% | 1 |
9 | CLIN EXPT MEDIKE | 1 | 50% | 0.2% | 1 |
10 | CNRSFRE 3517 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127889 | CATHEPSIN B//CATHEPSIN L//CATHEPSIN X |
2 | 0.0000125199 | CATHEPSIN D//PROCATHEPSIN D//UNITE HORMONES CANC |
3 | 0.0000091525 | LIPOFUSCIN//AGE PIGMENT//BROWN BOWEL SYNDROME |
4 | 0.0000090048 | APOPTOSIS INDUCING FACTOR//AIF//AMID |
5 | 0.0000077351 | MUCOLIPIDOSIS TYPE IV//MUCOLIPIN//MUCOLIPIDOSIS IV |
6 | 0.0000069975 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
7 | 0.0000069030 | FLASH WAVE LIGHT//FLUOROVISUALIZATION//ARTHROBACTER PHOTOGONIMOS |
8 | 0.0000066231 | APAF 1//CASPASE 2//RAIDD |
9 | 0.0000064786 | TAT BH4//MOL CELLULAR SIGNALING//BIOEMERGENCES IBISA |
10 | 0.0000058189 | CYSTATIN//HUMAN CYSTATIN C//CYSTEINE PROTEINASE INHIBITOR |